Biosig advances its pure™ system commercial launch to medical centers nationwide

Westport, ct, may 26, 2022 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”), a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced the rollout of the company's national commercial launch campaign.
BSGM Ratings Summary
BSGM Quant Ranking